Scarica l'app Stockscreener
7.17
5.91%
-0.45
Pre-mercato:
7.50
0.33
+4.60%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ADPT Giù?
Forum
Previsione
Adaptive Biotechnologies Corp Borsa (ADPT) Ultime notizie
Adaptive Biotechnologies director sells shares worth $70,500 By Investing.com - Investing.com Canada
Adaptive Biotechnologies director sells shares worth $402,270 - Investing.com
Adaptive Biotechnologies director sells shares worth $70,500 - Investing.com
Adaptive Biotechnologies director sells shares worth $402,270 By Investing.com - Investing.com UK
Adaptive Biotechnologies Executives Sell Shares - TradingView
Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma - The Manila Times
US Bancorp DE Sells 43,819 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Insider Selling: Adaptive Biotechnologies Co. (NASDAQ:ADPT) CEO Sells $819,109.98 in Stock - Defense World
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Down 6.5% on Insider Selling - Defense World
Adaptive Biotechnologies director sells $124,372 in stock By Investing.com - Investing.com Australia
Adaptive Biotechnologies CEO Chad Robins sells $1.6 million in stock By Investing.com - Investing.com Australia
Adaptive Biotechnologies’ chief commercial officer Sharon Benzeno sells $311,792 in stock By Investing.com - Investing.com South Africa
Principal Financial Group Inc. Purchases Shares of 143,444 Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Adaptive Biotechnologies president Julie Rubinstein sells $415,539 in stock By Investing.com - Investing.com Australia
Adaptive Biotechnologies CFO sells shares worth $72,072 By Investing.com - Investing.com South Africa
Adaptive Biotechnologies’ chief scientific officer sells $675k in stock By Investing.com - Investing.com South Africa
Adaptive Biotechnologies chief people officer sells $145,845 in stock - Investing.com
Adaptive Biotechnologies chief people officer sells $145,845 in stock By Investing.com - Investing.com Australia
Adaptive Biotechnologies director sells $124,372 in stock - Investing.com India
Adaptive Biotechnologies’ chief scientific officer sells $675k in stock - Investing.com India
Adaptive Biotechnologies president Julie Rubinstein sells $415,539 in stock - Investing.com
Adaptive Biotechnologies CEO Chad Robins sells $1.6 million in stock - Investing.com
Adaptive Biotechnologies’ chief commercial officer Sharon Benzeno sells $311,792 in stock - Investing.com
Private Advisor Group LLC Makes New $264,000 Investment in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Holdings Increased by Rhumbline Advisers - Defense World
D.A. Davidson & CO. Buys 6,725 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Adaptive Biotechnologies’ (ADPT) “Overweight” Rating Reiterated at Piper Sandler - Defense World
Cathie Wood’s Ark Invest Makes Bold Moves: Buys BEAM & NU, Sells MELI & ADPT - Apna Kal
Cathie Wood's Ark Invest Loads Up On Beam Therapeutics, Nu Holdings: Offloads MercadoLibre, Adaptive BiotechnologiesARK Fintech Innovation ETF (ARCA:ARKF), Adaptive Biotechnologies (NASDAQ:ADPT) - Benzinga
Adaptive Biotechnologies CEO Chad Robins sells over $2.4m in stock By Investing.com - Investing.com South Africa
Adaptive Biotechnologies CEO Chad Robins sells over $2.4m in stock - Investing.com Canada
Cathie Wood’s ARK buys Beam Therapeutics, sells Adaptive Biotech stock - Investing.com India
Cathie Wood's ARK buys Beam Therapeutics, sells Adaptive Biotech stock By Investing.com - Investing.com Australia
Cathie Wood's ARK buys Beam Therapeutics, sells Adaptive Biotech stock - Investing.com
Adaptive Biotechnologies CEO Chad Robins sells $3.99 million in shares By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies CEO Chad Robins sells $3.99 million in shares - Investing.com India
Adaptive Biotechnologies CEO Chad M Robins Sells Over $3.9 Million in Company Stock - TradingView
ADPT stock soars to 52-week high, reaching $8.33 - MSN
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 7.9% Following Analyst Upgrade - Armenian Reporter
Scotiabank Forecasts Strong Price Appreciation for Adaptive Biotechnologies (NASDAQ:ADPT) Stock - Defense World
Legato Capital Management LLC Decreases Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 7.9% on Analyst Upgrade - MarketBeat
Scotiabank Issues Positive Forecast for Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price - MarketBeat
Adaptive Biotechnologies price target raised to $12 from $10 at Scotiabank - Yahoo Finance
Adaptive Biotechnologies targets $1,300 ASP for MRD tests in 2025 driven by pricing improvements - MSN
Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Tops Revenue Estimates - MSN
Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 1-Year High After Analyst Upgrade - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Down 5.2%Time to Sell? - MarketBeat
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2024 Earnings Call Transcript - Insider Monkey
ADPT stock soars to 52-week high, reaching $8.33 By Investing.com - Investing.com South Africa
1.39%
0.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):